These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 681748)

  • 1. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
    Santoli D; Trinchieri G; Lief FS
    J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D; Trinchieri G; Koprowski H
    J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
    Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
    Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.
    Andersson T; Stejskal V; Harfast B
    J Immunol; 1975 Jan; 114(1 Pt 1):237-43. PubMed ID: 803527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
    Rola-Pleszczynski M
    J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.
    Härfast B; Andersson T; Perlmann P
    J Immunol; 1975 Jun; 114(6):1820-3. PubMed ID: 1168673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
    Kreth HW; Wiegand G
    J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
    Kreth WH; Käckell MY; ter Meulen V
    J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.
    Greenberg SB; Criswell BS; Six HR; Couch RB
    J Immunol; 1977 Dec; 119(6):2100-6. PubMed ID: 334984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated cytotoxicity against Sendai-virus-infected cells.
    Ertl H; Koszinowski U
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):128-40. PubMed ID: 60844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between human lymphocytes and paramyxovirus-infected cells: adsorption and cytotoxicity.
    Härfast B; Andersson T; Stejskal V; Perlmann P
    J Immunol; 1977 Apr; 118(4):1132-7. PubMed ID: 300397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.